Cargando…

Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma

The purpose of this work was to develop a method for easily verifying that the activity or air kerma strength of pre‐assembled eye plaques, used in the treatment of ocular melanomas, agrees with the activity or air kerma strength called for in the treatment plan. A Capintec CRC‐7 Dose Calibrator wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmermann, L. W., Wilkinson, D. Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875515/
https://www.ncbi.nlm.nih.gov/pubmed/25207419
http://dx.doi.org/10.1120/jacmp.v15i4.4880
_version_ 1783310360719130624
author Zimmermann, L. W.
Wilkinson, D. Allan
author_facet Zimmermann, L. W.
Wilkinson, D. Allan
author_sort Zimmermann, L. W.
collection PubMed
description The purpose of this work was to develop a method for easily verifying that the activity or air kerma strength of pre‐assembled eye plaques, used in the treatment of ocular melanomas, agrees with the activity or air kerma strength called for in the treatment plan. A Capintec CRC‐7 Dose Calibrator with its standard vial/syringe sample holder was used to measure the activity of pre‐assembled COMS and Eye Physics EP917 eye plaques using IsoAid Advantage I‐125 seeds. Plaque activity measurements were made by placing the plaque face up in the center of a 5 cm tall Styrofoam insert in the source holder. Activity measurements were made with the source holder rotated to four angles (0°, 90°, 180°, and 270°). The average of these four values was converted to air kerma strength and divided by the assay air kerma strength, from the NIST traceable source calibration, and decayed to the plaque measurement date, to determine a plaque calibration factor. The average of the calibration factors for each plaque type was used to establish a calibration factor for each plaque type. Several partially loaded plaque configurations were included in this study and different methods were used to determine the effects of partial loading. This verification method is easy to implement with commonly available equipment and is effective in identifying possible errors. During this two‐year study, the air kerma strength of 115 eye plaques was checked and 11 possible errors were identified. PACS number: 87.55.Qr
format Online
Article
Text
id pubmed-5875515
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58755152018-04-02 Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma Zimmermann, L. W. Wilkinson, D. Allan J Appl Clin Med Phys Radiation Oncology Physics The purpose of this work was to develop a method for easily verifying that the activity or air kerma strength of pre‐assembled eye plaques, used in the treatment of ocular melanomas, agrees with the activity or air kerma strength called for in the treatment plan. A Capintec CRC‐7 Dose Calibrator with its standard vial/syringe sample holder was used to measure the activity of pre‐assembled COMS and Eye Physics EP917 eye plaques using IsoAid Advantage I‐125 seeds. Plaque activity measurements were made by placing the plaque face up in the center of a 5 cm tall Styrofoam insert in the source holder. Activity measurements were made with the source holder rotated to four angles (0°, 90°, 180°, and 270°). The average of these four values was converted to air kerma strength and divided by the assay air kerma strength, from the NIST traceable source calibration, and decayed to the plaque measurement date, to determine a plaque calibration factor. The average of the calibration factors for each plaque type was used to establish a calibration factor for each plaque type. Several partially loaded plaque configurations were included in this study and different methods were used to determine the effects of partial loading. This verification method is easy to implement with commonly available equipment and is effective in identifying possible errors. During this two‐year study, the air kerma strength of 115 eye plaques was checked and 11 possible errors were identified. PACS number: 87.55.Qr John Wiley and Sons Inc. 2014-07-08 /pmc/articles/PMC5875515/ /pubmed/25207419 http://dx.doi.org/10.1120/jacmp.v15i4.4880 Text en © 2014 The Authors. This is an open access article under the terms of the http://creativecommons.org/licenses/by/3.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Zimmermann, L. W.
Wilkinson, D. Allan
Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma
title Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma
title_full Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma
title_fullStr Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma
title_full_unstemmed Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma
title_short Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma
title_sort method for verifying the air kerma strength of i‐125 plaques for the treatment of ocular melanoma
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875515/
https://www.ncbi.nlm.nih.gov/pubmed/25207419
http://dx.doi.org/10.1120/jacmp.v15i4.4880
work_keys_str_mv AT zimmermannlw methodforverifyingtheairkermastrengthofi125plaquesforthetreatmentofocularmelanoma
AT wilkinsondallan methodforverifyingtheairkermastrengthofi125plaquesforthetreatmentofocularmelanoma